Controlled release oxybutynin formulations

Details Controlled release oxybutynin formulations Controlled release oxybutynin formulations

1994-03-04

1995-03-21

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

424468, 424469, 424484, 424485, 424488, A61K 922

Patent

active

053993594

ABSTRACT:
A solid oral sustained release oxybutynin formulation includes a sustained release matrix including a gelling agent, an inert pharmaceutical diluent, and a cationic cross-linking agent.

REFERENCES:
patent: 4303691 (1981-12-01), Sand et al.
patent: 4792452 (1988-12-01), Howard et al.
patent: 4795642 (1989-01-01), Cohen et al.
patent: 4824675 (1989-04-01), Wong et al.
patent: 4857331 (1989-08-01), Shaw et al.
patent: 4886669 (1989-12-01), Ventouras
patent: 4894232 (1990-01-01), Reiil et al.
patent: 4942040 (1990-07-01), Ragnarsson et al.
patent: 4968508 (1990-11-01), Oren et al.
patent: 5032406 (1991-07-01), Dansereau et al.
patent: 5047244 (1991-09-01), Sandvordecker et al.
patent: 5128143 (1992-07-01), Baichwal et al.
patent: 5135757 (1992-08-01), Baichwal et al.
patent: 5169639 (1992-12-01), Baichwal et al.
patent: 5271943 (1993-12-01), Bogart et al.
patent: 5330761 (1994-07-01), Baichwal
patent: 5330763 (1994-07-01), Gole et al.
CA 120:227001x.
CA 120:62297g.
Derwent On-Line Search.

Affiliated with

Also associated with

Rating

Controlled release oxybutynin formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Controlled release oxybutynin formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release oxybutynin formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1147458